John Brock-Utne

Stanford University Hospital operates as a hospital. The private company is based in Palo Alto, CA.

Spectros Corp. develops, markets, and licenses medical devices based on in vivo molecular optical technologies, including clinical devices for detection of ischemia and cancer. Its medical devices utilize optical technologies that speed diagnosis, enable real-time therapies and reduce complications. The company's flagship product, the T-Stat Tissue Oximeter, is a medical device that is sensitive to ischemia, an insufficient supply of oxygen to tissue. The firm is also developing molecular imaging contrast agents for surgical guidance during breast and prostate cancer surgeries. Spectros was incorporated on April 19, 1995 and is headquartered in Portola Valley, CA.